Reversal of experimental pulmonary hypertension by PDGF inhibition. - Wikidata - wikimedia - TriplyDB

Reversal of experimental pulmonary hypertension by PDGF inhibition.

Reversal of experimental pulmonary hypertension by PDGF inhibition.

http://www.wikidata.org/entity/Q34048479

about

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo Molecular pathogenesis of pulmonary arterial hypertension Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.The limits of oral therapy in pulmonary arterial hypertension management Immune and inflammatory mechanisms in pulmonary arterial hypertension Molecular mechanisms of pulmonary arterial remodeling Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats Role of platelet-derived growth factors in physiology and medicine Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease Platelet-derived growth factor maintains stored calcium through a nonclustering Orai1 mechanism but evokes clustering if the endoplasmic reticulum is stressed by store depletion Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension.Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension.Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension.Enhanced inflammatory cell profiles in schistosomiasis-induced pulmonary vascular remodeling.Identifying "super responders" in pulmonary arterial hypertension.The cancer theory of pulmonary arterial hypertension.PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension.Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies.Serotonin Signaling Through the 5-HT1B Receptor and NADPH Oxidase 1 in Pulmonary Arterial Hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

P2860

Q21284417-114150AA-9EEC-4F91-9D80-0495461D3A78 Q24306656-B56BB54E-BF28-4706-A30D-864C72768AAB Q24634317-9B9E24D7-57B5-40A4-BC03-56D61271A760 Q24658407-5D191DF4-7409-408C-BAFD-18AE6EC6418E Q25255769-974B0F7C-B2AE-45DC-AA7A-AFD1402FC953 Q26773209-0EBC4CC3-6323-4B90-8D97-0A4500B1BE26 Q26851508-13FDCB0F-38BC-4E99-B584-4C1D6C05C647 Q26991806-CFABA2BA-8337-4112-9A5C-E09EC682DEE4 Q27023074-E542AAA9-19BE-413C-B02E-4718DE3A8D29 Q27026643-628EC2A3-6EEB-48EC-959C-490538A56332 Q28078976-D9431F04-2157-4658-AB64-F03D40A4A272 Q28386966-F4EB63A4-C268-4204-8099-956E88410A6C Q28551385-FFCD5145-DD08-473D-AE47-AC2121348ED8 Q28567772-0BC70E19-9119-4D6A-8548-C897C1615F75 Q28578858-D2F38EB4-7768-4624-9D5A-781CCD162940 Q28586021-ADA7A32C-9F76-44D5-A0B2-8A782AFCB9E2 Q28730633-E5CE254D-3684-4C6A-A5CB-2303A42FF257 Q29615222-B3B136F3-722C-4ECA-8DAC-210E1891E914 Q30429980-28A51D38-73CE-47B3-AEB6-315B006A039E Q30537918-E438069B-5F2E-479F-BD9E-062DB77EA1A4 Q30945205-BF63E691-D627-4C1B-A735-57939B9F6F8B Q32884516-C09DFB47-429C-497D-AC9A-C93B6F9F27C4 Q33386662-036918DC-638B-4EC1-A8AE-E20148665E8D Q33393513-20388D65-33F5-4091-817E-6EAB9C9A5C70 Q33482818-FFC1D778-7BD8-4B24-9A3A-B9186F4174F0 Q33613561-F37789D6-1043-40EE-A914-87A4F44921E4 Q33660866-996FF942-2E6D-4E3C-BE04-54916AE910FF Q33729763-4408F822-6FD5-4A3D-B87B-7E115C7D9071 Q33737242-1160B485-3484-46AE-96CC-CF392996DDA0 Q33738610-A95DDFA4-4333-472B-BAEC-E21DEC1A7B95 Q33788452-E5F1E455-2696-429D-954F-47F01B7132B7 Q33788493-A0F36972-E3E7-4A3A-A472-5AD5B33A4FE1 Q33805920-BB540A00-F32D-42EA-A53F-766FA4C0E234 Q33810499-8AA38009-BD38-4247-9772-2A7952481039 Q33817590-5255947D-85F9-4513-8C69-FF3325AD7CBD Q33849207-2C5CD035-ED33-42AD-B1FD-90893FCAB443 Q33873485-36BC8E66-C7BC-407B-B986-9611C2DB9B32 Q33881508-A4540D92-D101-4270-90B0-72D45C2C07E7 Q33886299-3775CA41-433D-434C-9637-25BAFA4C69F4 Q33909480-C1DEB832-3C02-4F04-8460-6392A122441C

P2860

Reversal of experimental pulmonary hypertension by PDGF inhibition.

http://www.wikidata.org/entity/Q34048479

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@ast

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@en

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@nl

type

label

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@ast

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@en

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@nl

prefLabel

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@ast

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@en

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@nl

P1433

Q34048479-4F521480-5E02-4215-9B55-E3EC3C8EC7EE

P1476

Q34048479-AC3DEF09-FCB1-47F0-B6EA-075582549BF7

P2093

Q34048479-2AFDAAF9-4B88-469B-9810-C907B5A7D58C

Q34048479-454D9B82-0C2C-48A1-9F14-70FAEFEB0BD1

Q34048479-5F09ABFD-7119-4B4A-9408-29B9D480928B

Q34048479-D5CEDF42-2E4E-41B4-8394-0E20CE2EECF9

Q34048479-E9A9944E-0BF1-4450-98AF-7B3E0B9D23DF

P2860

Q34048479-023743E0-1452-4C26-A6C4-BF723697A187

Q34048479-05BD6C23-3849-4CCF-9821-33987B1C1E3C

Q34048479-12B79A27-E588-4CC3-881E-D9501158A3B4

Q34048479-1CB701ED-2241-4D31-9175-2B3403811C3B

Q34048479-20C2228E-0830-49FC-98BA-0AEA09D68D45

Q34048479-21231912-9913-434E-885F-64E701F9C2C3

Q34048479-2577F03A-FA71-4494-9691-590392B19333

Q34048479-34DE823D-8BAB-4373-98A1-DAD76AFB6759

Q34048479-37A07FF7-ACC0-4004-AB22-F9A2CDA463F8

Q34048479-3D8241E3-44F7-47F6-BA6B-B2C6FD9C5B5B

P304

Q34048479-621B9C03-539D-4C57-BCD9-42FC8F9AF56A

P31

Q34048479-89D4A689-689B-4C75-ADCD-00A2E6436F52

P356

Q34048479-862FA78B-B51F-49E9-B6CD-3D95CCE6579C

P407

Q34048479-E384A0CB-DC66-452C-9FAF-A9516A63DC55

P433

Q34048479-E31EC126-141C-4F27-AC7F-E4DEB5957C99

P478

Q34048479-D35FD879-57FF-4F5E-8CB0-8A583A419184

P50

Q34048479-376F3AC6-797A-4599-B4FD-F6C2CB41AAD0

Q34048479-540D3F12-9572-4A63-8005-827C217621AD

Q34048479-85925D79-4DF9-4DC7-937E-EE1A4E67148B

Q34048479-B8B47F91-BD00-4B55-8249-17CDE3500062

Q34048479-E6B42A8E-56FC-47DC-90C3-6B6C3D2A762E

Q34048479-F90659CB-E8C5-4E16-8A11-A51E340C8B65

P577

Q34048479-AA16DC90-6004-453D-BA1D-26EEC9DDCF2A

P698

Q34048479-6D2DD594-4D24-424A-ACDB-3C223658001F

P932

Q34048479-052CFC21-8B66-46F7-B2F9-03369B9629F4

P356

P1433

Journal of Clinical Investigation

P1476

Reversal of experimental pulmonary hypertension by PDGF inhibition.

@en

P2093

Eva Dony

http://www.w3.org/2001/XMLSchema#string

Hossein Ardeschir Ghofrani

http://www.w3.org/2001/XMLSchema#string

Markus Roth

http://www.w3.org/2001/XMLSchema#string

Rajkumar Savai

http://www.w3.org/2001/XMLSchema#string

Ying Ju Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Mechanism of action and in vivo role of platelet-derived growth factor

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor

PDGF-D, a new protease-activated growth factor

A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling

Signal transduction via platelet-derived growth factor receptors

The mitogen-activated protein kinase signal transduction pathway

Inhaled iloprost for severe pulmonary hypertension.

Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.

Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes.

P304

2811-2821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI24838

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Akylbek S. Sydykov

Friedrich Grimminger

Ralph T Schermuly

Soni Savai Pullamsetti

Norbert Weissmann

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16200212

http://www.w3.org/2001/XMLSchema#string

P932

1236676

http://www.w3.org/2001/XMLSchema#string